Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The maker of popular GLP-1 agonists Wegovy and Ozempic said technology from OpenAI, the company behind ChatGPT, will allow it to sift through and make sense of massive datasets to identify potential new uses for its diabetes and obesity treatments.
Chapter, a technology company based in New York City, said it tripled its revenue last year by filling a market niche designing technology for seniors—specifically, those who have questions about the Medicare program.
The publicly traded EHR and cloud healthcare IT infrastructure company confirmed in a filing with the U.S. Securities and Exchange Commission that hackers were able to breach its network in March for roughly eight hours, gaining partial access to patient record stores. The incident is being investigated.
The policy shift by Aetna to reimburse hospital stays of fewer than five days as outpatient observation encounters went into effect in January. The insurer implemented the policy to reduce friction with hospitals that previously had to seek approval for inpatient reimbursement, which was often denied. Jefferson Health is challenging the changes in court.
The pharmacy chain was accused of filling “millions” of unlawful prescriptions for opioids and other controlled substances. Despite agreeing to the payout, the company does not admit wrongdoing.
The two companies have been unable to assuage antitrust concerns raised by the Department of Justice. A magistrate will attempt to hammer out acceptable terms for the home healthcare merger at a conference scheduled for August.
The company said part of its network has been encrypted. However, it told the Securities and Exchange Commission it is still able to deliver dialysis care to patients.
UnitedHealth Group said it is seeking repayment of “interest-free” advances distributed to providers struggling during the shutdown of claims processing caused by the ransomware attack on Change Healthcare.
Monoclonal antibody therapies will be the first drugs permitted to take advantage of alternatives, including advanced lab simulations and artificial intelligence. A pilot framework to phase out the decades-long requirement for animal testing will be rolled out in the coming year, the FDA said.